Reszon Dengue Rapid lgG/lgM Test

DPP® HIV-Syphilis Assay

Fighting the Syphilis and HIV Epidemics: Voices from the Field – NCSD Webinar

DPP® HIV-Syphilis Assay

CE-Marked

FDA Approved

Patented DPP® technology allows for higher sensitivity and specificity
2 test results in a single sample
Small sample volume: 10 μl
DPP sample tainer included for safe and closed sample handling

A dual rapid test for the detection of antibodies to HIV 1/2 and Treponema pallidum in fingerstick whole blood, venous whole blood, serum or plasma specimens.


Platform	Immunochromatographic Assay
Format	Cassette
Detection	HIV-1 and HIV-2 antibodies
Specimen	Whole blood, serum & plasma
Assay Time	15 minutes
Shelf Life*	24 months

*From date of manufacture

Dual Path Platform

Chembio’s proprietary DPP® technology differs from classical lateral flow tests by operating in a manner similar to that of the sequential ELISA format which is not sensitive to the “Hook Effect”.

DPP® Technological Advantages:

Enhanced multiplex capability up to 8 biomarkers with results in minutes
Significantly increased analytical and clinical sensitivity
Ability to effectively resolve normal aggregation/agglutination migratory issues, a common concern in lateral flow assays with large particle analytes (e.g., bacteria)
Adaptable to multiple sample types such as fingerstick blood, oral fluid, venous whole blood, serum and plasma

Do you still have questions?

For Technical Support please call 1300 418 188 9am-7pm AEST / 9am-8pm AEDT, 7 days per week
Or contact us via the form below and a member of the team will get back to you.

To contact your local state/territory health department click on the following link:
https://www.health.gov.au/about-us/contact-us/local-state-and-territory-health-departments